Press Release

Best in Class: Scottsdale Wound Management Guide

Comprehensive pocket handbook offers differential diagnosis and treatment options at your fingertips

Malvern, PA (June 8, 2009) – Proper wound care management has become one of the top concerns for many clinicians across various medical specialties. Treatment is specific to the wound type, the patient and the long-term care plan and requires ongoing assessment. Read More

Non-Accredited Education

Taking the Trauma Out of Burn Trauma
Complimentary On-Demand Webcast
Non-Accredited

The Importance of Advanced Dressing Technology in Managing Wounds and the Risk of Infection
Complimentary On-Demand Webcast
Non-Accredited

Heel Pressure Ulcers: A to Z
Complimentary On-Demand Webcast
Non-Accredited

LIVE WEBCAST - Head Over Heels and Butts 3.0
Complimentary On-Demand Webcast
Non-Accredited

Company investigates experimental cell-based wound therapy

Healthpoint Ltd (Fort Worth, Tex) has enrolled the first of a planned 235-subject Phase II dose response study investigating an experimental, cell-based wound therapy, HP802-247, which is intended for the treatment of venous leg ulcers. HP802-247 is a topical spray containing living keratinocytes and fibroblasts. Twenty-eight investigators in 18 states are conducting the study.

The trial is the second of two planned-dose response trials, extending the dose range being tested and exploring two plausible dose frequencies. Enrollment into the trial is preceded by screening and run-in phases and is expected to continue through the middle of 2010. The first trial showed promising results over a four-fold range of cell concentrations administered weekly. The trial is evaluating the benefits and safety of enhancing wound healing by using metabolically active donor cells to support the patient’s own skin cells’ healing ability. HP802-247 utilizes allogeneic cells, which are living human cells derived from an individual donor that are subsequently grown in a tissue culture, and then applied to an unrelated patient. The wound therapy product consists of both keratinocytes and fibroblasts, the two major cell types found in human skin. The cells are sprayed onto the wound surface in a self-polymerizing protein mesh intended to help the cells adhere to the tissue.

For more information, visit www.healthpoint.com.





For more information on using oxygen therapy in wound care, please see the April 2010 issue of Today’s Wound Clinic, available at www.todayswoundclinic.com.

OWM Monthly Poll



All Subscriptions are FREE to qualified wound care professionals

OWM

  • Subscribe to:
  • Journal
  • Digital Journal
  • E-News
  • RSS feed

CLICK HERE TO CONTINUE »

Sage Online Library




REVIEW OUR OTHER
WOUND CARE BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • WOUNDS
  • today's wound clinic
  • Podiatry Today
  • Skin and Aging

Google Analytics Alternative